• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型靶向脂肪酸酰胺水解酶(FAAH)和可溶性环氧化物水解酶(sEH)的双重抑制剂:恶二唑类似物的设计、合成及体外评价

Novel dual inhibitor targeting FAAH and sEH: Design, synthesis, and in-vitro evaluation of oxadiazole analogues.

作者信息

Salehi Maryam, Sedaghat Anna, Bayanati Maryam, Mahboubi Rabbani Mohammad Ismail, Rezaee Elham, Tabatabai Sayyed Abbas

机构信息

Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Chemistry Department, Loughborough University, Loughborough Leics, LE11 3TU, UK.

出版信息

Mol Divers. 2025 Jul 7. doi: 10.1007/s11030-025-11267-7.

DOI:10.1007/s11030-025-11267-7
PMID:40622672
Abstract

Fatty acid amide hydrolase (FAAH) enzyme, as a potential therapeutic target for the treatment of pain and inflammation, is responsible for decomposing fatty acid amides like endocannabinoids. One attractive technique for increasing the efficacy of FAAH inhibitors is to generate antinociception and anti-inflammatory effects via another route, such as soluble epoxide hydrolase (sEH) inhibition, at the same time. In this study, two series of structures bearing oxadiazole rings as dual inhibitors of FAAH/sEH were designed, synthesized, and biologically evaluated. Most compounds showed an excellent affinity towards the active sites of both enzymes compared to the standard ligands of JZL-195 and AUDA. Among all the synthesized compounds, compound 7f was a more effective inhibitor with IC values of 1.2 nM and 18 nM on FAAH and sEH enzymes, respectively. The results of the in-vitro evaluation were significantly consistent with the docking results.

摘要

脂肪酸酰胺水解酶(FAAH)作为治疗疼痛和炎症的潜在治疗靶点,负责分解内源性大麻素等脂肪酸酰胺。提高FAAH抑制剂疗效的一种有吸引力的技术是同时通过另一条途径,如抑制可溶性环氧化物水解酶(sEH),产生抗伤害感受和抗炎作用。在本研究中,设计、合成并对两个含有恶二唑环的系列结构作为FAAH/sEH双重抑制剂进行了生物学评价。与JZL-195和AUDA的标准配体相比,大多数化合物对两种酶的活性位点都表现出优异的亲和力。在所有合成化合物中,化合物7f是一种更有效的抑制剂,对FAAH和sEH酶的IC值分别为1.2 nM和18 nM。体外评价结果与对接结果显著一致。

相似文献

1
Novel dual inhibitor targeting FAAH and sEH: Design, synthesis, and in-vitro evaluation of oxadiazole analogues.新型靶向脂肪酸酰胺水解酶(FAAH)和可溶性环氧化物水解酶(sEH)的双重抑制剂:恶二唑类似物的设计、合成及体外评价
Mol Divers. 2025 Jul 7. doi: 10.1007/s11030-025-11267-7.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
6
Genetic characterization of the endocannabinoid system and psychiatric features in patients with migraine and medication overuse headache.偏头痛和药物过度使用性头痛患者内源性大麻素系统的基因特征及精神症状
Cephalalgia. 2025 Jul;45(7):3331024251314460. doi: 10.1177/03331024251314460. Epub 2025 Jul 2.
7
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.阿达木单抗、依那西普和英夫利昔单抗治疗成人类风湿关节炎有效性的系统评价及其成本效益的经济学评估。
Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. doi: 10.3310/hta10420.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
9
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

本文引用的文献

1
A Comprehensive Review of Soluble Epoxide Hyådrolase Inhibitors Evaluating their Structure-Activity Relationship.可溶性环氧化物水解酶抑制剂的全面评价:评估其结构-活性关系。
Mini Rev Med Chem. 2023;23(1):99-117. doi: 10.2174/1389557522666220531152812.
2
Biological activity of oxadiazole and thiadiazole derivatives.恶二唑和噻二唑衍生物的生物活性。
Appl Microbiol Biotechnol. 2022 May;106(9-10):3489-3505. doi: 10.1007/s00253-022-11969-0. Epub 2022 May 14.
3
Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review.
内源性大麻素系统作为炎症性肠病有前途的治疗靶点——系统评价。
Front Immunol. 2021 Dec 22;12:790803. doi: 10.3389/fimmu.2021.790803. eCollection 2021.
4
Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.进一步探讨双重可溶性环氧水解酶/脂肪酸酰胺水解酶抑制剂的构效关系。
Bioorg Med Chem. 2021 Dec 1;51:116507. doi: 10.1016/j.bmc.2021.116507. Epub 2021 Nov 11.
5
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases.内源性大麻素系统:治疗各种疾病的潜在靶点。
Int J Mol Sci. 2021 Aug 31;22(17):9472. doi: 10.3390/ijms22179472.
6
Quinazoline-4(3H)-one derivatives as novel and potent inhibitors of soluble epoxide hydrolase: Design, synthesis and biological evaluation.喹唑啉-4(3H)-酮衍生物作为新型强效可溶性环氧化物水解酶抑制剂的设计、合成与生物评价。
Bioorg Chem. 2020 Jun;99:103736. doi: 10.1016/j.bioorg.2020.103736. Epub 2020 Mar 20.
7
A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents.脂肪酸酰胺水解酶(FAAH)抑制剂作为潜在治疗药物的视角综述。
Eur J Med Chem. 2020 Feb 15;188:111953. doi: 10.1016/j.ejmech.2019.111953. Epub 2019 Dec 30.
8
Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors.3-苯基戊二酸的新型酰胺衍生物作为有效的可溶性环氧化物水解酶抑制剂。
Mol Divers. 2021 Feb;25(1):45-53. doi: 10.1007/s11030-019-10023-y. Epub 2019 Dec 23.
9
Issues in the future development of new analgesic drugs.新型镇痛药未来发展中的问题。
Curr Opin Support Palliat Care. 2019 Jun;13(2):107-110. doi: 10.1097/SPC.0000000000000425.
10
Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors.双可溶性环氧化物水解酶/脂肪酸酰胺水解酶抑制剂的设计与效能
ACS Omega. 2018 Oct 31;3(10):14076-14086. doi: 10.1021/acsomega.8b01625. Epub 2018 Oct 25.